尿液中的四糖化物分泌作为肝脏糖原储存疾病中的生物标志物

Ruben J Overduin1, Candelas Gross-Valle2, Joost Groen2

  • 1University of Groningen, University Medical Center Groningen, Beatrix Children's Hospital, Section of Metabolic Diseases, Groningen, the Netherlands; UMCG Center of Expertise for Carbohydrate, Fatty Acid Oxidation and Ketone Bodies Disorders, University Medical Center Groningen, Groningen, the Netherlands.

PubMed
概括

尿液四糖化物 (Glc4) 是诊断和监测肝脏糖原储存疾病 (GSD) 的有前途的生物标志物. Glc4水平可以随着GSD管理而降低,并在肝移植后恢复正常.